XML 52 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Summary of Significant Research and Development and General and Administrative Expense to CODM

The table below summarizes the significant research and development and general and administrative expense categories regularly provided to the CODM:

 

 

 

Years Ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Revenue

 

$

68,696

 

 

$

48,727

 

Operating expenses

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

Direct research and development expenses by product candidate:

 

 

 

 

 

 

PBGENE-HBV external development costs

 

 

16,111

 

 

 

9,261

 

PBGENE-3243 external development costs

 

 

9,808

 

 

 

352

 

Platform development and early-stage research expenses:

 

 

 

 

 

 

Employee-related costs (other than share-based compensation)

 

 

18,753

 

 

 

19,788

 

Share-based compensation

 

 

2,560

 

 

 

3,642

 

Laboratory supplies and services

 

 

3,016

 

 

 

5,741

 

CMOs and outsourced research and development

 

 

1,083

 

 

 

4,753

 

Facility-related costs, laboratory equipment, and maintenance

 

 

3,082

 

 

 

3,308

 

Depreciation and amortization

 

 

2,718

 

 

 

4,022

 

Licensing fees and other research and development costs

 

 

2,428

 

 

 

2,508

 

Total research and development expenses

 

$

59,559

 

 

$

53,375

 

General and administrative expense

 

 

 

 

 

 

Employee-related costs (including share-based compensation)

 

 

21,861

 

 

 

22,517

 

Consulting and professional services

 

 

6,327

 

 

 

7,445

 

Other operating expenses and all other costs

 

 

7,111

 

 

 

9,126

 

Total general and administrative expenses

 

$

35,299

 

 

$

39,088

 

Total operating expenses

 

$

94,858

 

 

$

92,463

 

Operating loss

 

 

(26,162

)

 

 

(43,736

)

Total other income (expense)

 

 

33,329

 

 

 

1,209

 

Income (loss) from continuing operations

 

$

7,167

 

 

$

(42,527

)

Loss from discontinued operations

 

 

 

 

 

(18,792

)

Net income (loss)

 

$

7,167

 

 

$

(61,319

)